• Genesco posted a net loss of $14.8 million, or $1.42 per share, narrowing from a $21.2 million loss a year earlier.
• Net sales rose 2.8% to $487 million, helped by a 2% increase in comparable sales.
• Operating margin improved to (3.2)% from (5.9)% a year earlier, while pretax loss narrowed to $15.9 million from $29.7 million.
• Results included a $10.1 million asset impairment and other gain, including a $13.4 million gain tied to payment card interchange fee litigation.
• Journeys comparable sales climbed 5%, while Schuh comparable sales fell 9% and Johnston & Murphy comparable sales increased 7%.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Genesco Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-266889), on June 11, 2026, and is solely responsible for the information contained therein.